Peer-reviewedCC BYFrontiers in cardiovascular medicine
Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies
- 1Department of Cardiovascular Medicine, Fuling People’s Hospital of Chongqing , ,
- 2Department of Cardiovascular Medicine, Meishan People’s Hospital , ,
Related
- Closing the Diagnostic Gap in Transthyretin Amyloid Cardiomyopathy
- Scleroderma-Like Phenotype in a Patient With Transthyretin Cardiac Amyloidosis and Acromegaly: A Triple Diagnostic Challenge.
- How to individualize device therapy in transthyretin cardiac amyloidosis: A dyssynchrony-based case report.
- Delayed Diagnosis of Hereditary Transthyretin Cardiac Amyloidosis Presenting with Autonomic Neuropathy: A Case Report
- Demographic Representation in Clinical Trials for Transthyretin-Associated Cardiac Amyloidosis: A Systematic Review
BibTeX
@article{yi2026closing,
title = {{Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies}},
author = {Zhengjun Yi and Peng Li and Xueqian Wang},
journal = {Frontiers in cardiovascular medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13658949},
note = {CC BY},
}
RIS
TY - JOUR
TI - Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies
AU - Zhengjun Yi
AU - Peng Li
AU - Xueqian Wang
PY - 2026
DA - 2026/10/16
JO - Frontiers in cardiovascular medicine
UR - https://europepmc.org/article/PMC/PMC13658949
SN - 2297-055X
ER -